Our findings indicated upregulated expression of SLC2A3, MMP11, SCARA3, GPC1, OLFM2, L1CAM, and CRABP2 in CRC cells, with the expression of PHGR1, TFF1, and CLCA1 being diminished. The gene discussed is SCARA3; the disease is colorectal carcinoma.